The makers of the popular prescription pain medications Darvon and Darvocent have agreed to voluntarily withdraw the drugs from the U.S. drug market, see the CNN article here.
The U.S. Food and Drug Administration (FDA) asked Xanodyne Pharmaceuticals to remove the drug from the market after a recent study showed that the medication could cause serious and potentially fatal heart rhythm abnormalities in some patients.
The FDA does not believe that that the pain reducing efficacy of the drug outweighs the potential risks involved with taking the medications. The FDA has also asked generic manufacturers to their products as well.
The FDA is urging patients currently taking Darvon, Darvocet or other generic versions of propoxyphene to consult with their physicians as soon as possible about switching to an alternative medication.
Propoxyphene was first approved for use by the FDA in 1957 to treat mild to moderate pain. Since 1978 the Administration has received two requests to remove the drug from the market, but concluded that the benefits of the drug outweighed any potential health risks each time.
Individuals who have suffered heart rhythm abnormalities and other heart problems while taking Darvocet, Darvon, or any other form of propoxyphene should contact with a drug recall attorney for a free consultation to discuss their legal rights.
The Legal Examiner and our Affiliate Network strive to be the place you look to for news, context, and more, wherever your life intersects with the law.
Comments for this article are closed.